MedPath

Obesity and asthma: effect of bariatric surgery on lung function, inflammation and quality of life.

Completed
Conditions
adiposity
overweight
10003018
10006436
Registration Number
NL-OMON33646
Lead Sponsor
Sint Franciscus Gasthuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
100
Inclusion Criteria

Age > 18 and < 50 year.
For the asthma patients: physician diagnosed, persistent asthma
Able to perform a technical correct and reproducable lung function
Acceptable operative risk
BMI > 35 kg/m2.
Approval for 1 year follow-up visits

Exclusion Criteria

Smoking > 10 sig/d or > 10 pack years (PY)
COPD or other pulmonary pathology apart from asthma.
Pregnancy
Exacerbation in 4 weeks prior to screening
Use of oral steroids
Psychological instability

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The group size is powered on the expected change in FEV1/FVC ratio before and<br /><br>after bariatric surgery. Based on our pilot study and the results in the<br /><br>literature we assume that in obese patients with asthma the FEV1/FVC ratio<br /><br>increases from 72% to 75% (SD ± 6). </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints are symptom score, FeNO levels and inflammatory parameters<br /><br>(see study design).</p><br>
© Copyright 2025. All Rights Reserved by MedPath